Author:
Gan Shanling,Ruan Lingru,Xu Xinyi,Luo Lirong,Huo Yu,Jiang Jiaming,Zhang Xiumin,Shang Changhua
Funder
Guangxi Key Research and Development Program
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Wang S, Lin Y, Tang Z (2010) Research progress on the protection of tetramethylpyrazine in different kinds of damage of nervous system and its mechanisms. Chin Pharmacol Bull 26(4):438–442
2. Lin J, Wang Q, Zhou S, Xu S, Yao K (2022) Tetramethylpyrazine: a review on its mechanisms and functions. Biomed Pharmacother 150:113005. https://doi.org/10.1016/j.biopha.2022.113005
3. Zhang Y, He L, Ma C, Wang C, Zhou H, Guo C et al (2022) Research progress on the pharmacy of tetramethylpyrazine and its pharmacological activity in cardiovascular and cerebrovascular diseases. J Pharm Pharmacol 74(6):843–860. https://doi.org/10.1093/jpp/rgac015
4. Shao Z, Wang L, Liu S, Wang X (2017) Tetramethylpyrazine protects neurons from oxygen-glucose deprivation induced death. Med Sci Monit 23:5277–5282. https://doi.org/10.12659/msm.904554
5. Meng Z, Chen H, Meng S (2021) The roles of tetramethylpyrazine during neurodegenerative disease. Neurotox Res 39(5):1665–1677. https://doi.org/10.1007/s12640-021-00398-y